Peak Asset Management LLC lowered its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 4.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 3,889 shares of the medical research company’s stock after selling 176 shares during the period. Peak Asset Management LLC’s holdings in Thermo Fisher Scientific were worth $679,000 as of its most recent filing with the SEC.

Other institutional investors have also recently added to or reduced their stakes in the company. Proficio Capital Partners LLC grew its position in shares of Thermo Fisher Scientific by 71.5% during the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock worth $105,000 after acquiring an additional 253 shares during the last quarter. Chicago Partners Investment Group LLC bought a new position in shares of Thermo Fisher Scientific during the second quarter worth about $108,000. Cribstone Capital Management LLC grew its position in shares of Thermo Fisher Scientific by 8.7% during the second quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock worth $109,000 after acquiring an additional 50 shares during the last quarter. Sharkey Howes & Javer grew its position in shares of Thermo Fisher Scientific by 1.0% during the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock worth $113,000 after acquiring an additional 7 shares during the last quarter. Finally, CWM LLC grew its position in Thermo Fisher Scientific by 17.0% in the 2nd quarter. CWM LLC now owns 710 shares of the medical research company’s stock valued at $124,000 after buying an additional 103 shares in the last quarter. Institutional investors and hedge funds own 83.52% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Peak Asset Management LLC Sells 176 Shares of Thermo Fisher Scientific Inc (TMO)” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at https://www.thecerbatgem.com/2017/09/16/peak-asset-management-llc-sells-176-shares-of-thermo-fisher-scientific-inc-tmo.html.

A number of equities analysts recently issued reports on the stock. Deutsche Bank AG set a $200.00 target price on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research report on Saturday, June 10th. Wells Fargo & Company reiterated an “outperform” rating and issued a $200.00 target price (up previously from $195.00) on shares of Thermo Fisher Scientific in a research report on Thursday, July 13th. Bank of America Corporation reiterated a “buy” rating and issued a $210.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Friday, July 21st. Cleveland Research upgraded shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research report on Thursday, July 20th. Finally, BidaskClub lowered shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. One equities research analyst has rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. Thermo Fisher Scientific currently has an average rating of “Buy” and an average price target of $193.56.

Shares of Thermo Fisher Scientific Inc (TMO) opened at 190.63 on Friday. The firm has a market capitalization of $74.37 billion, a P/E ratio of 33.21 and a beta of 1.05. The firm has a 50-day moving average of $180.21 and a 200-day moving average of $170.53. Thermo Fisher Scientific Inc has a one year low of $139.07 and a one year high of $194.30.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, topping the Zacks’ consensus estimate of $2.27 by $0.03. The firm had revenue of $5 billion during the quarter, compared to analyst estimates of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The company’s revenue was up 10.2% on a year-over-year basis. During the same period last year, the company earned $2.03 earnings per share. On average, equities analysts predict that Thermo Fisher Scientific Inc will post $9.35 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 15th will be given a $0.15 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.31%. Thermo Fisher Scientific’s payout ratio is 10.45%.

In other news, Director C Martin Harris sold 360 shares of the business’s stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $180.97, for a total transaction of $65,149.20. Following the completion of the transaction, the director now directly owns 5,312 shares in the company, valued at approximately $961,312.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP Peter E. Hornstra sold 3,894 shares of the business’s stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $185.18, for a total value of $721,090.92. Following the transaction, the vice president now owns 19,751 shares of the company’s stock, valued at $3,657,490.18. The disclosure for this sale can be found here. Over the last quarter, insiders sold 22,738 shares of company stock valued at $4,021,512. Corporate insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.